$AIMD π Exciting Update! πAinos has signed an MOU with Taiwan Tanabe Seiyaku Co., Ltd. to advance the production and marketing of Sjgren's syndrome drug, VELDONA, in Taiwan. This international partnership taps into Taiwan Tanabe's strong pharmaceutical expertise and market presence.
As part of Mitsubishi Tanabe Pharma Corporation in Japan, Taiwan Tanabe excels in key therapeutic areas, addressing the significant need for effective Sjgren's syndrome treatments. Ainos has conducted three Phase 3 studies showing significant benefits in increasing saliva secretion for Sjgren's syndrome patients. Despite its impact, there is still a big need for effective treatments. Together, they are committed to improving patient lives!